SEC Info - Caldera Pharmaceuticals Inc - ‘8-K’ for 3/4/13

SEC Info℠

Home

Help

Please Sign In

Caldera Pharmaceuticals Inc – ‘8-K’ for 3/4/13 – EX-16.1

On: Friday, 3/8/13, at 2:10pm ET · For: 3/4/13 · Accession #: 1213900-13-1007 · File #: 0-54748

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/08/13  Caldera Pharmaceuticals Inc       8-K:4,9     3/04/13    2:36K                                    Edgar Agents LLC/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     24K 
 2: EX-16.1     Letter Dated March 8, 2013 From Sherb & Co., LLP    HTML      6K 
                          to the Securities and Exchange                         
                          Commission.

EX-16.1 — Letter Dated March 8, 2013 From Sherb & Co., LLP to the Securities and Exchange Commission.

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EXHIBIT 16.1

March 8, 2013

Securities and Exchange Commission

100 F Street, N.W.

Washington, DC

Dear Sirs/Madams:

We have read Item 4.01 of the Caldera Pharmaceuticals, Inc. Form 8-K dated March 4, 2013, and agree with the statements concerning our firm contained therein.

Very truly yours,

/s/ Sherb & Co., LLP

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

Filed on:	3/8/13	None on these Dates
For Period End:	3/4/13
		List all Filings

↑Top

Filing Submission 0001213900-13-001007 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)